Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

GSK’s asthma drug Nucala meets co-primary endpoints in SYNAPSE trial

pharmaceutical-business-reviewApril 08, 2020

Tag: GSK , asthma drug , Nucala , SYNAPSE

PharmaSources Customer Service